Pharmaceutisch weekblad

December 1981, Volume 3, Issue 1, pp 876–879 | Cite as

Serumbinding en ziekteprocessen

• Authors
• Authors and affiliations

• F. M. Belpaire

Article

First Online: 01 December 1981

• 16 Downloads
• 1 Citations

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Literatuur

1. Andreasen, F. (1974)Acta Pharmacol. Toxicol. 34, 284–294.CrossRefGoogle Scholar
2. Bachmann, K., enR. Shapiro (1977)Clin. Pharmacokin. 2, 110–126.CrossRefGoogle Scholar
3. Belpaire, F.M., M.G. Bogaert, M. Rosseneu enO. Teirlynck (1981)Brit. J. Clin. Pharmacol., 11, 125P-126P.Google Scholar
4. Blaschke, T.F. (1977)Clin. Pharmacokin. 2, 32–44.CrossRefGoogle Scholar
5. Boobis, S.W. (1977)Clin. Pharmacol. Therap. 22, 147–153.CrossRefGoogle Scholar
6. Borga, O. (1979)Advances in Pharmacology and Therapeutics. Vol. 7. Pergamon Press, Oxford, 143.Google Scholar
7. Chakrabarti, S.K., R. Laliberte enJ. Brodeur (1976)Biochem. Pharmacol. 25, 2515–2521.CrossRefPubMedGoogle Scholar
8. Craig, W.A., M.A. Evenson, K.P. Sawer enJ.P. Wagnild (1976)J. Lab. Clin. Med. 87, 637–647.PubMedGoogle Scholar
9. Danon, A., enZ. Chen (1979)Clin. Pharmacol. Therap. 25, 316–321.CrossRefGoogle Scholar
10. Dromgoole, S.H. (1977)J. Pharmacol. Exp. Therap. 191, 318–323.Google Scholar
11. Fremstad, D., K. Bergerud, J.F.W. Haffner enP.K.W. Lunde (1976)Europ. J. Clin. Pharmacol. 10, 441–411.CrossRefGoogle Scholar
12. Goodmann, W.S. (1958)J. Am, Chem. Soc. 80, 3892–3898.CrossRefGoogle Scholar
13. Gugler, R., enD.L. Azarnoff (1976)Clin. Pharmacokin. 1, 25–35.CrossRefGoogle Scholar
14. Kates, R.E., T.D. Sokoloski enT.J. Comstock (1978)Clin. Pharmacol. Therap. 23, 30–35.CrossRefGoogle Scholar
15. Mussche, M.M., F.M. Belpaire enM.G. Bogaert (1975)Europ. J. Clin. Pharmacol., 9, 69–71.CrossRefGoogle Scholar
16. Nilsen, O.G. (1976)Biochem. Pharmacol. 25, 1007–1012.CrossRefPubMedGoogle Scholar
17. Odar-Cederlöf, I. (1977)Clin. Pharmacokin. 2, 147–153.CrossRefGoogle Scholar
18. Piafsky, K. (1980)Clin. Pharmacokin. 5, 246–262.CrossRefGoogle Scholar
19. Piafsky, K., O. Borga, I. Odar-Cederlöf, C. Johansson enF. Sjoqvist (1978)New Engl. J. Med. 299, 1435–1439.CrossRefPubMedGoogle Scholar
20. Reidenberg, M.M. (1976)Clin. Pharmacokin. 1, 121–125.CrossRefGoogle Scholar
21. Routledge, P.A., W.W. Stargel, G.S. Wagner enD.G. Shand (1980)Brit. J. Clin. Pharmacol. 9, 438–439.CrossRefGoogle Scholar
22. Schneider, R.E., H. Bishop enC.F. Hawkins (1979)Brit. J. Clin. Pharmacol. 8, 43–47.CrossRefGoogle Scholar
23. Shoeman, D.W., enD.L. Azarnoff (1972)Pharmacology 7, 169–177.CrossRefPubMedGoogle Scholar
24. Sjöholm, I., A. Kober, I. Odar-Cederlöf enO. Borga (1976)Biochem. Pharmacol. 25, 1205–1213.CrossRefPubMedGoogle Scholar
25. Storstein, L. (1976)Clin. Pharmacol. Therap. 20, 15–23.CrossRefGoogle Scholar
26. Tillement, J.P., F. Lhoste enJ.F. Giudicelli (1978)Clin. Pharmacokin. 3, 144–154.CrossRefGoogle Scholar

Copyright information

© Bohn, Scheltema & Holkema 1981

Authors and Affiliations

• F. M. Belpaire
  • 1

1. 1.J. F. & C. Heymans Instituut voor Farmakodynamie en Terapie der RijksuniversiteitGentBelgië